Product Information
CHLORDIAZEPOXIDE 5 MG CAPSULE is a generic product labeled by Epic Pharma LLC, priced at $0.1877 per EA under NDC 42806056401. Its NADAC has been published 240 times since Jan 19, 2022.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Epic Pharma LLCNDC
42806056401
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHLORDIAZEPOXIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA085461FDA Approved
Before 1982
TE Code
AB
On Market Since
11/9/2021
Pharmacological Classes
Price Statistics
The NADAC for CHLORDIAZEPOXIDE 5 MG CAPSULE has been published 240 times since Jan 19, 2022, and over the history we have for it it has risen 71.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1877 per EA |
|---|---|
| All-time high | $0.1898 (Feb 15, 2023) |
| All-time low | $0.1095 (Jan 19, 2022) |
| 52-week high | $0.1895 |
| 52-week low | $0.1846 |
| Median price | $0.1870 |
| Average price | $0.1802 |
| Largest weekly change | +62.0% (Mar 23, 2022) |
| Weeks tracked | 240 |
| Tracking since | Jan 19, 2022 |
1W
N/A
1M
N/A
3M
-0.9%
6M
-0.3%
1Y
+1.7%
3Y
+0.4%
5Y
N/A
All
+71.4%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CHLORDIAZEPOXIDE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Epic Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CHLORDIAZEPOXIDE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORDIAZEPOXIDE 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CHLORDIAZEPOXIDE 5 MG CAPSULE, manufactured by Epic Pharma LLC, is $0.1877 per EA (NDC 42806056401), effective Aug 19, 2026.
How has the price of CHLORDIAZEPOXIDE 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CHLORDIAZEPOXIDE 5 MG CAPSULE has risen 71.4%. It has been tracked across 240 weekly CMS publications since Jan 19, 2022.
What are the highest and lowest recorded NADAC prices for CHLORDIAZEPOXIDE 5 MG CAPSULE?
Since Jan 19, 2022, the NADAC for CHLORDIAZEPOXIDE 5 MG CAPSULE has ranged from a low of $0.1095 (Jan 19, 2022) to a high of $0.1898 (Feb 15, 2023), with a median of $0.1870 per EA.
Are there cheaper alternatives to CHLORDIAZEPOXIDE 5 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of CHLORDIAZEPOXIDE 5 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLORDIAZEPOXIDE 5 MG CAPSULE?
CHLORDIAZEPOXIDE 5 MG CAPSULE (NDC 42806056401) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.